Tuesday, December 08, 2020 12:01:07 AM
https://www.nurixtx.com/research-development/strategic-partnerships/
Wellington and Baker Brothers are among Institutional Ownership and Shareholders:
https://fintel.io/so/us/nrix?__cf_chl_jschl_tk__=c9a7439112376e9f70de91c1316dfcc7e26d3519-1607403189-0-AT-0XpHMlNGWmcEzimwDKelDxLnOK6gsd8IihalGD8DcDe76KQlrWnh2Q1G3OLjfsidXSQyjVOkcCg3lXIXgKu6RIlw8DMusjRJpgnTzQP2qkahd1WSCP-5At2BI9Udfzc2vqpmlZOV3prAMIdFIh1_urJuBNq7hGlM4oSEJKFEFs8WDerUagukeDe9yBmvVg0Ne17vR8ByRaN-BlyHHxPWeTerJ_ZHoD1jnsxFYInhjhkK-XNkhe3BJ0Wzq3782kDVndNMNsb1glMkmm_NlSnc8Xbwve1nF3nGShcpgUxA-nefEgd9L74SzGXF1WftTIX4HYgwtb1BRzq82RClNfm9dr9Xb-hKp3xKKiYL4k9KfqV9OAePxDJoYgKqLUziXoA
Recent NRIX News
- Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares • GlobeNewswire Inc. • 04/16/2024 10:21:52 PM
- Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering • GlobeNewswire Inc. • 04/12/2024 03:38:26 AM
- Nurix Therapeutics Announces Proposed Public Offering • GlobeNewswire Inc. • 04/11/2024 08:00:01 PM
- Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update • GlobeNewswire Inc. • 04/10/2024 11:00:00 AM
- Nurix Therapeutics Reports First Clinical Evidence of CNS Activity of NX-5948, a Brain-Penetrant, Orally Available, BTK Degrader in Development for B Cell Malignancies • GlobeNewswire Inc. • 04/09/2024 05:15:00 PM
- Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6 • GlobeNewswire Inc. • 04/09/2024 11:00:00 AM
- Nurix Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 04/03/2024 11:00:00 AM
- Nurix Therapeutics Announces Extension of Strategic Collaboration with Gilead Sciences • GlobeNewswire Inc. • 04/02/2024 11:00:00 AM
- Nurix Therapeutics is Part of a Team of International Oncology Experts Selected as Cancer Grand Challenges Awardees to Address Pediatric Cancers Using Targeted Protein Degradation (TPD) • GlobeNewswire Inc. • 03/25/2024 11:00:00 AM
- Nurix Presents the Discovery and Chemical Structure of First-in-Class CBL-B Inhibitor NX-1607 at the American Chemical Society (ACS) Meeting • GlobeNewswire Inc. • 03/20/2024 01:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 11:02:50 AM
- Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 Trial • GlobeNewswire Inc. • 03/11/2024 11:00:00 AM
- Nurix Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/06/2024 09:00:00 PM
- Nurix Therapeutics Announces Presentations at the American Association for Cancer Research (AACR) 2024 Annual Meeting • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2024 12:20:25 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 09:22:10 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/15/2024 09:51:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:01:51 PM
- Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides a Corporate Update • GlobeNewswire Inc. • 02/15/2024 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 12:23:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 12:23:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 12:23:04 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:51:28 PM
- Nurix Therapeutics Announces Publication in the Journal Science Identifying a New Class of BTK Mutations That Are Susceptible to NX-2127, a Novel BTK and IKZF1/3 Degrader • GlobeNewswire Inc. • 02/01/2024 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 11:53:11 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM